8-KThe WireRoutine
Bylaw Amendment
Filed Jul 22, 2024 · 1y ago · Accession 0001193125-24-182231
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Artiva Biotherapeutics, Inc.
- Ticker
- ARTV
- CIK
- 1817241
- Form type
- 8-K
- Filing date
- Jul 22, 2024
- Report date
- Jul 22, 2024
- Document
- d863184d8k.htm
- Size
- 46 KB